SavedAdd your journal

Journals / Hacettepe Sağlık İdaresi Dergisi / 2021 / Cilt: 24 - Sayı: 4

THE POTENTIAL ROLE AND SIGNIFICANCE OF EQUITY CROWDFUNDING FOR FINANCING R&D EXPENDITURES IN TURKISH PHARMACEUTICAL INDUSTRY

PAYA DAYALI KİTLE FONLAMASININ TÜRK İLAÇ SEKTÖRÜNDE AR-GE HARCAMALARININ FİNANSMANINDAKİ ROLÜ VE ÖNEMİ

Burak PİRGAİP
Elif GÜR
Selim CAN
Pages
941–958
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In line with our examinations and evaluations as well as our policy recommendations to take timely actions against potential practical problems, equity crowdfunding model stands out as a great opportunity for pharmaceutical start-ups and ventures to finance their R&D expenditures in Turkey.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:COVID-19 pandemic, which has surrounded the world, has already proven the fragility of not only the health of human but also the health systems of countries as a whole.
📊
Key Findings & Data:This fragility may have been arising from the fact that business ventures at the research and development (R&D) phase in particular have not been able to benefit from financing opportunities at all in current health systems.
💡
Conclusion & Impact:In line with our examinations and evaluations as well as our policy recommendations to take timely actions against potential practical problems, equity crowdfunding model stands out as a great opportunity for pharmaceutical start-ups and ventures to finance their R&D expenditures in Turkey.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Paya dayalı kitle fonlaması · AR-GE · ilaç sektörü

Abstract

COVID-19 pandemic, which has surrounded the world, has already proven the fragility of not only the health of human but also the health systems of countries as a whole. This fragility may have been arising from the fact that business ventures at the research and development (R&D) phase in particular have not been able to benefit from financing opportunities at all in current health systems. In this study, we examine the “equity crowdfunding” model as a contemporary and innovative means of finance with respect to the extant literature and international practices and we evaluate the new capital market regulations on equity crowdfunding in Turkey. In line with our examinations and evaluations as well as our policy recommendations to take timely actions against potential practical problems, equity crowdfunding model stands out as a great opportunity for pharmaceutical start-ups and ventures to finance their R&D expenditures in Turkey.

Özet

Tüm dünyayı kuşatan COVID-19 pandemisi sadece insan sağlığının değil bir bütün olarak ülkelerin sağlık sistemlerinin de ne kadar kırılgan olduğunu göstermiştir. Bu kırılganlık, mevcut sağlık sistemlerinde, özellikle araştırma-geliştirme (AR-GE) safhalarındaki girişimlerin, finansman olanaklarından yeterince istifade edememelerinden kaynaklanabilmektedir. Bu çalışmada, çağdaş ve yenilikçi bir finansman yöntemi olarak “paya dayalı kitle fonlaması” modeli konuya ilişkin literatür ve uluslararası uygulama örnekleri çerçevesinde incelenmekte ve Türkiye’de yakın zamanda hayata geçirilen paya dayalı kitle fonlamasına yönelik sermaye piyasası mevzuatı değerlendirilmektedir. Yapılan inceleme ve değerlendirmeler ile uygulamada karşılaşılabilecek tereddütlerin zamanında giderilebilmesine yönelik öneriler doğrultusunda, Türkiye’de ilaç AR-GE harcamalarının paya dayalı kitle fonlaması modeliyle finansmanının erken aşama ilaç girişimleri için son derece önemli bir fırsat oluşturduğu sonucuna ulaşılmaktadır

🔖

Cite This Article

PİRGAİP, B., GÜR, E., CAN, S. (2022). THE POTENTIAL ROLE AND SIGNIFICANCE OF EQUITY CROWDFUNDING FOR FINANCING R&D EXPENDITURES IN TURKISH PHARMACEUTICAL INDUSTRY. Hacettepe Sağlık İdaresi Dergisi, Cilt: 24 - Sayı: 4, 941–958. https://ajindex.com/articles/530941

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Acticor (2015, 26 Ocak). Acticor biotech bets on crowdfunding for health and successfully raises ıts first seed round https://acticor-biotech.com/acticor-biotech-bets-on-crowdfunding-for-health-and-successfully-raises-its-first-seed-round/
  2. Adams, L., & Constantine, D. E. (2015, 29 Haziran ). Mintz. Crowdfunding and IP in health and biotech start-ups (Part 3): Potential dangers https://www.mintz.com/insights-center/viewpoints/2015-06-29-crowdfunding-and-ip-health-and-biotech-start-ups-part-3
  3. Agrawal, A., Catalini, C., & Goldfarb, A. (2014). Some simple economics of crowdfunding. Innovation Policy and The Economy, 14(1), 63-97.
  4. Azar, S., & Mackey, T. (2015). Crowdfunding: A new untapped opportunity for biotechnology start-ups? Journal of Commercial Biotechnology, 21(4), 15-28.
  5. Bagna, S. (2019). Complementarity of signals in early-stage equity investment decisions: Evidence from a randomized field experiment. Management Science, 65(2), 933-952.
  6. Bakanlar Kurulu (2017). “7061 Sayılı “Bazı Vergi Kanunları ile Diğer Bazı Kanunlarda Değişiklik Yapılmasına Dair Kanun”, 5 Aralık 2017 tarih ve 30261 sayılı Resmi Gazete. (17.06.2021). https://www.resmigazete.gov.tr/eskiler/2017/12/20171205-12.htm.
  7. Battaglia, F., Busato, F., & Manganiello, M. (2020). Equity crowdfunding: Brave market or safe haven for the crowd during the COVID-19 crisis? http://dx.doi.org/10.2139/ssrn.3666021.
  8. Belleflamme, P., Omrani, N., & Peitz, M. (2015). The economics of crowdfunding platforms. Information Economics and Policy, 33, 11-28. BioSpace (2015, 03 Şubat). Crowdfunding: EyeBrain raises €1.3 million ($1.47 million) on Anaxago https://www.biospace.com/article/releases/crowdfunding-b-eyebrain-b-raises-1-3-million-1-47-million-on-b-anaxago-b-/
  9. CCAF (2020). The global alternative finance market benchmarking report. Cambridge Centre for Alternative Finance, Cambridge. Chakradhar, S. (2015). In new crowdfunding trend, donors decide fate of clinical trials. Nature Medicine, 21(2), 101-102.
  10. Cumhurbaşkanlığı (2018). “Bakanlıklara Bağlı, İlgili, İlişkili Kurum ve Kuruluşlar İle Diğer Kurum ve Kuruluşların Teşkilatı Hakkında Cumhurbaşkanlığı Kararnamesi”, 15 Temmuz 2018 tarih ve 30479 sayılı Resmi Gazete. (10.06.2021). https://www.resmigazete.gov.tr/eskiler/2018/07/20180715-1.pdf.
  11. Global Innovation Index (2020). The Global Innovation Index 2020: Who will finance innovation?. WIPO, Geneva. Crowdcube (2017, 12 Nisan). More financial returns for Crowdcube investors as Celixir delivers 2.7x return https: